Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo.
American Heart Journal.
Times cited: 63
Predictors of diastolic dysfunction among minority patients with newly diagnosed type 2 diabetes.
Diabetes Research and Clinical Practice.
Times cited: 7